HR 5298 · 115th Congress 2017โ€“2019, ended

Modernizing Drug Enforcement Act of 2018

Latest action · Apr 30, 2018 Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 15, 2018
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Modernizing Drug Enforcement Act of 2018

This bill deems a drug or substance that acts as an opioid mu receptor agonist (e.g., morphine) to be in schedule I of the Controlled Substances Act, subject to certain exceptions. A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Cosponsors 1

Members who signed on, in the order they did. All signed on Mar 15, 2018.

SeatCosponsorSigned on
D-NYThomas R. SuozziOriginalMar 15, 2018

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Mar 15, 2018
Health Subcommittee
Referred Mar 16, 2018
HouseJudiciary Committee
Referred Mar 15, 2018
Crime and Federal Government Surveillance Subcommittee
Referred Apr 30, 2018

Actions 4

Everything that happened, newest first.

  1. Apr 30, 2018Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
  2. Mar 16, 2018Referred to the Subcommittee on Health.
  3. Mar 15, 2018Introduced in House
  4. Mar 15, 2018Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article 1, Section 8, Clause 1, with respect to the power to ``lay and collect Taxes, Duties, Imposts, and Excises,'' and to provide for the ``general Welfare of the United States.''

The sponsor’s statement, as printed in the Congressional Record, vol. 164, no. 46, March 15, 2018, page H1652.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Controlled Substances Act to deem drugs or other substances that act as opioid mu receptor agonists to be in schedule I, subject to exceptions for substances intended for legitimate medical or research use, and for other purposes.
Short Titles as Introduced
Modernizing Drug Enforcement Act of 2018

Subjects

Assigned by the Library of Congress. Policy area: Crime and Law Enforcement.

Text 1

Each version as it was printed, newest first.

  1. Mar 15, 2018Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.